Fibromuscular dysplasia, most commonly found in the renal or carotid arteries, often goes undiagnosed, even though the condition may affect three- to five-percent of the U.S. patient population. What are symptoms of FMD, and in what patients should physicians screen for FMD, despite the absence of symptom presentation? Dr. Jeffrey Olin, professor of cardiology and director of vascular medicine at Mount Sinai in New York City, offers his insights on FMD, as Dr. Olin has dedicated much of his professional career to spreading awareness about the condition. Dr. Alfred Bove hosts.
When to Screen for Fibromuscular Dysplasia
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
Fibromuscular dysplasia, most commonly found in the renal or carotid arteries, often goes undiagnosed, even though the condition may affect three- to five-percent of the U.S. patient population. What are symptoms of FMD, and in what patients should physicians screen for FMD, despite the absence of symptom presentation? Dr. Jeffrey Olin, professor of cardiology and director of vascular medicine at Mount Sinai in New York City, offers his insights on FMD, as Dr. Olin has dedicated much of his professional career to spreading awareness about the condition. Dr. Alfred Bove hosts.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
CME/CE
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
0.25 credits
<p>Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy</p>
CME/CE
FCS and SHTG: Are We Meeting the Need?
0.25 credits
<p>FCS and SHTG: Are We Meeting the Need?</p>
CME/CE
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
1.00 credits
<p>Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future</p>
CME/CE
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
0.25 credits
<p>Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective</p>
MinuteCE®
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
1.00 credits
<p>Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time</p>
MinuteCE®
Level Up Your Skills: Tailoring Management of HF
0.75 credits
<p>Level Up Your Skills: Tailoring Management of HF</p>
Cardiology
Mode of Death in Patients With HFmrEF/HFpEF: The FINEARTS-HF Trial
<p><span data-teams="true">Mode of Death in Patients With HFmrEF/HFpEF: The FINEARTS-HF Trial</span> </p>
CME/CE
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
<p>FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?